JNK Signaling Promotes Bladder Cancer Immune Escape by Regulating METTL3-Mediated m6A Modification of PD-L1 mRNA.
Zegui NiPengli SunJin ZhengMingqing WuCongcong YangMaosheng ChengMingwei YinChengying CuiGuangxian WangLin YuanQian GaoYang LiPublished in: Cancer research (2022)
The identification of a novel m6A-dependent mechanism underlying immune system evasion by bladder cancer cells reveals JNK signaling as a potential target for bladder cancer immunotherapy.